562 results match your criteria: "Azienda Ospedaliera-Universitaria "Ospedali Riuniti"[Affiliation]"
Clin Exp Med
August 2024
UOS Tumori Polmonari, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.
Immune checkpoint inhibitors (ICIs) have revolutionized the management of advanced non-small cell lung cancer (NSCLC), although patient survival is still unsatisfactory. Accurate predictive markers capable of personalizing the treatment of patients with NSCLC are still lacking. Circulating extracellular vesicles involved in cell-to-cell communications through miRNAs (EV-miRs) transfer are promising markers.
View Article and Find Full Text PDFNeurourol Urodyn
November 2024
Neuro-Urology, Spinal Unit, Niguarda Hospital, University of Milan, Milan, Italy.
Front Cardiovasc Med
July 2024
Heart Failure Unit Centro Cardiologico Monzino, IRCCs, Milan, Italy.
Background: A sex-based evaluation of prognosis in heart failure (HF) is lacking.
Methods And Results: We analyzed the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score registry, which includes HF with reduced ejection fraction (HFrEF) patients. A cross-validation procedure was performed to estimate weights separately for men and women of all MECKI score parameters: left ventricular ejection fraction (LVEF), hemoglobin, kidney function assessed by Modification of Diet in Renal Disease, blood sodium level, ventilation vs.
Ital J Pediatr
July 2024
Department of Medicine and Surgery, Clinica Pediatrica, Azienda Ospedaliera-Universitaria, University of Parma, 43123, Parma, Italy.
Drug hypersensitivity reactions are common in children. Risk factors predisposing to IgE-mediated drug allergies and delayed drug reactions are a matter of debate. Gender, age, previous reactions to the same drug or to another drug, reduced drug metabolism, chronic diseases, polypharmacy, drug doses are linked with the onset of hypersensitivity reactions in some children.
View Article and Find Full Text PDFLancet Haematol
August 2024
Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Evans syndrome is a rare disease marked by a severe clinical course, high relapse rate, infectious and thrombotic complications, and sometimes fatal outcome. Management is highly heterogeneous. There are several case reports but few large retrospective studies and no prospective or randomised trials.
View Article and Find Full Text PDFBlood Adv
August 2024
Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
Trials
July 2024
Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
J Hand Surg Glob Online
March 2024
Clinical Orthopedics, Department of Clinical and Molecular Science, Polytechnic University of Marche, Ancona, Italy.
Cancers (Basel)
May 2024
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seragnoli, 40126 Bologna, Italy.
The administration of TKIs after Allo-SCT in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) remains controversial, and the TKI approach (prophylactic, pre-emptive or salvage) is still heterogeneous in transplant centers. In this context, very little is known about the feasibility and safety of third-generation TKIs. In this paper, we analyze the efficacy and safety of ponatinib (PONA) administered after Allo-SCT to prevent cytologic relapse of Ph + ALL.
View Article and Find Full Text PDFNeurol Sci
November 2024
Emergency Department Stroke Unit, Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Background: Mechanical thrombectomy (MT) was found to be beneficial in acute ischemic stroke patients with anterior tandem occlusion (a-TO). Instead, little is known about the effectiveness of MT in stroke patients with posterior tandem occlusion (p-TO). We aimed to compare MT within 24 h from last known well time in ischemic stroke patients with p-TO versus a-TO.
View Article and Find Full Text PDFHematol Oncol
July 2024
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
Front Immunol
May 2024
Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Front Cardiovasc Med
May 2024
Cardiovascular Center, University Hospital and Health Services of Trieste, Trieste, Italy.
Background: Heart failure (HF) significantly affects the morbidity, mortality, and quality of life of patients. New therapeutic strategies aim to improve the functional capacity and quality of life of patients while controlling HF-related risks. Real-world data on both the functional and cardiopulmonary exercise capacities of patients with HF with reduced ejection fraction upon sacubitril/valsartan use are lacking.
View Article and Find Full Text PDFCancers (Basel)
May 2024
Department of Hematology, Azienda Ospedaliera Universitaria, Ospedali Riuniti di Ancona, Via Conca 71, 60126 Ancona, Italy.
Despite the availability of target drugs in the first and second line, only 30% of FLT3mut AMLs are cured. Among the multiple mechanisms of resistance, those of FLT3mut LSC are the most difficult to eradicate because of their metabolic and genomic characteristics. Reactivation of glycogen synthesis, inhibition of the RAS/MAPK pathway, and degradation of FLT3 may be potential aids to fight the resistance of LSC to FLT3i.
View Article and Find Full Text PDFEur J Surg Oncol
July 2024
Breast Center, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 8, 00184, Rome, Italy.
Brain Spine
April 2024
Neurosurgery Clinic, Azienda Ospedaliera Universitaria di Verona, Verona, Italy.
Introduction: Intraoperative Neurophysiological Monitoring (IOM) is widely used in neurosurgery but specific guidelines are lacking. Therefore, we can assume differences in IOM application between Neurosurgical centers.
Research Question: The section of Functional Neurosurgery of the Italian Society of Neurosurgery realized a survey aiming to obtain general data on the current practice of IOM in Italy.
Life (Basel)
April 2024
Department of Maxillofacial Surgery, University of Siena, 53100 Siena, Italy.
Purpose: This pilot study aims to evaluate the feasibility and effectiveness of computer-assisted surgery protocol with 3D-preformed orbital titanium mesh (3D-POTM), using presurgical virtual planning and intraoperative navigation in primary inferomedial orbital fracture reconstruction.
Methods: Between March 2021 and March 2023, perioperative data of patients undergoing surgery for unilateral inferomedial orbital fracture treated with 3D-POTM were analyzed. Presurgical virtual planning with a Standard Triangle Language file of preformed mesh was conducted using the mirrored unaffected contralateral side as a reference, and intraoperative navigation was used.
Neuroradiology
June 2024
Department of Radiology, USL Toscana Centro, Florence, Italy.
G Ital Cardiol (Rome)
May 2024
Malattie Cardiovascolari, IRCCS Ospedale Policlinico San Martino, Genova.
Cancer Immunol Immunother
April 2024
Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
EClinicalMedicine
June 2024
Division of Hematology, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.
Endosc Int Open
April 2024
Gastroenterology and Digestive Endoscopy Unit, Pancreas Institute, University of Verona, Verona, Italy.
The optimal number of needle passes during endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is not yet established. We aimed to perform a per-pass analysis of the diagnostic accuracy of EUS-FNB of solid pancreatic lesions using a 22G Franseen needle. Consecutive patients with solid pancreatic lesions referred to 11 Italian centers were prospectively enrolled.
View Article and Find Full Text PDFBr J Dermatol
July 2024
Department of Dermatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Neuroradiology
June 2024
Department of Radiology, USL Toscana Centro, Florence, Italy.
Purpose: To evaluate safety and efficacy of the novel percutaneous interspinous device (PID) for the treatment of symptomatic degenerative lumbar spinal stenosis (DLSS) in 3 different centers.
Methods: From November 2016 to March 2020, 255 patients (male 125, mean age 71.2 years old range 49-91 years old) with neurogenic claudication, confirmed by electromyography, related to mono or bi-segmental lumbar central canal and/or foraminal stenosis were enrolled in the study.
Int J Cardiol
July 2024
Cardio-Thoracic and Vascular Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy; Department of Vascular Physiopathology, IRCCS Neuromed, Pozzilli (IS), Italy. Electronic address: